.

Deeper Knowledge, Faster

  • Predict branded drug patent expiration
  • Drug patents in 130+ countries
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

QuintilesIMS
Colorcon
Queensland Health
Novartis
Healthtrust
Moodys
Johnson and Johnson
Harvard Business School
Deloitte
Daiichi Sankyo

Generated: July 25, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 087666

« Back to Dashboard
NDA 087666 describes SULFINPYRAZONE, which is a drug marketed by Par Pharm, Barr, Vangard, Watson Labs, and Ivax Pharms, and is included in eight NDAs. Additional details are available on the SULFINPYRAZONE profile page.

The generic ingredient in SULFINPYRAZONE is sulfinpyrazone. There are four drug master file entries for this compound. Additional details are available on the sulfinpyrazone profile page.

Summary for NDA: 087666

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Therapeutic Class:Antigout Agents
Formulation / Manufacturing:see details

Summary for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:CAPSULE;ORALStrength200MG
Approval Date:Sep 17, 1982TE:RLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Chubb
Mallinckrodt
Cerilliant
Argus Health
McKinsey
Citi
Daiichi Sankyo
McKesson
Accenture
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot